Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

COVID-19: Answering the Questions, Part 16

In Part 16 of this ongoing series, listen to an update on immunity to emerging COVID-19 variants from Sharon R. Lewin, AO, FRACP, PhD, FAHMS, followed by her answers to COVID-19 questions.
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Released: February 12, 2021

In this episode, Part 16 of an ongoing series, Sharon R. Lewin, AO, FRACP, PhD, FAHMS, provides a brief update on emerging COVID-19 variants and their potential impacts on vaccine efficacy. After the update, Professor Lewin answers questions submitted by healthcare professionals on various aspects of COVID-19.

Presenter:

Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Director, The Peter Doherty Institute for Infection and Immunity
Melbourne Laureate Professor of Infectious Diseases 
University of Melbourne
Consultant Infectious Diseases Physician
Alfred Hospital and Royal Melbourne Hospital
Melbourne, Australia

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by
Gilead Sciences, Inc.

Related Content

In this presentation, Dr. Sharon Lewin reviews investigational therapies for COVID-19: TMPRSS2 inhibitors, CRISPR-Cas13, and interferon lambda.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: March 18, 2021

Arthur Kim, MD, provides an update on the latest COVID-19 treatment options and guidelines and answers questions in the CCO Infectious Disease podcast

Arthur Kim, MD Released: March 9, 2021

Dr. Vikram Mukherjee reviews recent studies on thromboprophylaxis and anticoagulation in persons with COVID-19, from Clinical Care Options (CCO)

Vikramjit Mukherjee, MD Released: February 19, 2021

Dr. Jens D. Lundgren reviews diagnostic tests for SARS-CoV-2 infection, contrasting antigen tests with nucleic acid assays, and describing how to use and interpret antigen tests from Clinical Care Options (CCO)

Jens D. Lundgren, MD, DMSc Released: January 29, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue